Search Results - "Swallow, E. A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease by Swallow, E. A., Aref, M. W., Chen, N., Byiringiro, I., Hammond, M. A., McCarthy, B. P., Territo, P. R., Kamocka, M. M., Winfree, S., Dunn, K. W., Moe, S. M., Allen, M. R.

    Published in Osteoporosis international (01-09-2018)
    “…Summary This work examines the skeletal accumulation of fluorescently tagged zoledronate in an animal model of chronic kidney disease. The results show higher…”
    Get full text
    Journal Article
  2. 2

    Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study by Aref, M.W., Swallow, E.A., Metzger, C.E., Chen, N., Moe, S.M., Allen, M.R.

    Published in Osteoporosis international (01-08-2019)
    “…Summary Interventions that alter PTH levels in an animal model of chronic kidney disease have effects on the perfusion of bone and bone marrow. Introduction…”
    Get full text
    Journal Article
  3. 3

    Angina pectoris: Effects of lidoflazine on exercise tolerance and chest pain by Jenkins, Michael D., Swallow, Edith A., Abdel-Hadi, Omar, Kidner, Peter H.

    Published in The American journal of cardiology (01-07-1981)
    “…In a double-blind study involving 24 patients, treatment with lidoflazine in comparison with placebo was associated with a significant improvement in exercise…”
    Get full text
    Journal Article